SBIR-STTR Award

Mouse Models For Studies Of Aging And Neuronal Diseases
Award last edited on: 7/11/14

Sponsored Program
SBIR
Awarding Agency
NIH : NIA
Total Award Amount
$100,000
Award Phase
1
Solicitation Topic Code
-----

Principal Investigator
James G Geistfeld

Company Information

Taconic Biosciences Inc (AKA: Taconic Farms Inc)

One Hudson City Centre
Hudson, NY 12534
   (518) 697-3900
   custserv@taconic.com
   www.taconic.com
Location: Single
Congr. District: 19
County: Columbia

Phase I

Contract Number: 1R43AG015308-01
Start Date: 00/00/00    Completed: 00/00/00
Phase I year
1998
Phase I Amount
$100,000
The hallmark of normal aging and of many neurodegenerative diseases is the derangement of the cytoskeleton of the neuron and the deposition of these proteins as filamentous tangles. Research into this manifestation has been slow because human neurofilaments are unique and different from those of laboratory animals. However, many aspects of neurofilament assembly and function are best studied in the neuron -- a largely post- mitotic cell. Thus, ironically, laboratory animals are the experimental systems of choice. Herein we propose to create transgenic mouse lines in which the mouse's neurofilament genes are inactivated and replaced with a set of human neurofilament genes. In Phase I of this process, we will create a stable line of mice in which the genes encoding the three murine subunits have been inactivated by a targeted gene disruption. This mutant line will be examined for neuropathology, reproductive characteristics, or a failure to thrive that might compromise its use as a host for human neurofilament transgenes that will be introduced in Phase II of this application. In Phase II of this application we will produce lines of mice that have been "humanized" with respect to their neurofilament genes and networks using the standard transgenic mouse paradigm. If the project is successful, Taconic Farms will distribute these animals under its exclusive license for knockout rodents. PROPOSED COMMERCIAL APPLICATION The mouse lines that will be created under this grant will be powerful, new research tools for the study of aging and neuro-degenerative diseases, for toxicologic studies of suspected environmental toxins, and the development of new CNS drugs. Proposed Commercial Application:The mouse lines that will be created under this grant will be powerful, new research tools for the study of aging and neuro-degenerative diseases, for toxicologic studies of suspected environmental toxins, and the development of new CNS drugs.

Thesaurus Terms:
disease model, gene expression, laboratory mouse, model design /development, neurofilament, transgenic animal aging, nervous system disorder gene targeting, human genetic material tag

Phase II

Contract Number: ----------
Start Date: 00/00/00    Completed: 00/00/00
Phase II year
----
Phase II Amount
----